Recombinant interferon-gamma (rIFN-gamma) in dermatology

This paper gives a short review on the function, pharmacokinetics, and therapeutic application of recombinant interferon-gamma (rIFN-gamma) in dermatology. Simultaneously, our own experiences are presented for 57 patients (phase II study) suffering from genital warts (21 patients), psoriatic arthritis (10 patients), psoriasis vulgaris (three patients), malignant melanoma (six patients), bowenoid papulosis (four patients), Behcet's disease (four patients), basal cell carcinoma (six patents), as well as herpes simplex recidivans, epidermodysplasia verruciformis, and mycosis fungoides (one patient each).
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Source Type: research